We are studying whether a single injection of rituximab can improve heart function in patients who have had a heart attack. This trial compares its effects to a placebo to see if it helps reduce heart damage.
Health conditions and diseases that the clinical trial is designed to study and treat.
ST Segment Elevation Myocardial Infarction (STEMI) is a severe type of heart attack where there is a prolonged blockage of blood supply, leading to significant damage to the heart muscle. It is characterized by specific changes on an electrocardiogram (ECG).
Acute Myocardial Infarction (AMI) refers to the sudden blockage of blood flow to the heart muscle, resulting in damage. Symptoms can include chest pain, shortness of breath, and other signs of distress.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.
